| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9328379 | Gynecologic Oncology | 2005 | 9 Pages |
Abstract
The Roche AMPLICOR® HPV test is comparable to other HPV tests (HCII, PCR) in detecting CIN in MAPS. However, more data are clearly needed on the performance of AMPLICOR test in management of abnormal PAP and particularly as a screening tool.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Joseph Monsonego, Jean Marc Bohbot, Giuseppe Pollini, Claude Krawec, Catherine Vincent, Isabelle Merignargues, Fatima Haroun, Patrice Sednaoui, Laura Monfort, Roger Dachez, Kari Syrjänen,